Reduction in clonogenic survival of sodium-iodide symporter (NIS)-positive cells following intracellular uptake of 99mTc versus 188Re

International Journal of Radiation Biology

Volumn 88, Issue 12, 2012, Pages 991-997

  Freudenberg, Robert ^a   Wendisch, Maria ^a   Runge, Roswitha ^a   Wunderlich, Gerd ^a   Kotzerke, Jörg ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

188Re; 99mTc; Auger emitters; Clonogenic cell survival; PC Cl3; Radionuclides

Indexed keywords

RHENIUM 188; SODIUM IODIDE SYMPORTER; TECHNETIUM 99M;

ANIMAL CELL; CELL SURVIVAL; CELL TRANSPORT; CLONOGENIC CELL SURVIVAL; COLONY FORMATION; CONFERENCE PAPER; CYTOTOXICITY; DOSIMETRY; DRUG UPTAKE; GAMMA IRRADIATION; HALF LIFE TIME; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL; THYROID CELL; X RAY;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL SURVIVAL; EXTRACELLULAR SPACE; INTRACELLULAR SPACE; MONTE CARLO METHOD; ORGANOTECHNETIUM COMPOUNDS; RADIOISOTOPES; RADIOMETRY; RATS; RHENIUM; SYMPORTERS; THYROID GLAND;

RATTUS;

EID: 84870567205     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2012.728303     Document Type: Conference Paper

References (35)

1. Agostinelli S, Allison J, Amako K, Apostolakis J, Araujo H, Arce P, Asai M, Axen D, Banerjee S, Barrand G, et al. 2003. GEANT4 - a simulation toolkit. Nuclear Instruments and Methods in Physics Research Section A - Accelerators Spectrometers Detectors and Associated Equipment 506: 250-303.
2. Bockisch A, Grunwald F, Kotzerke J. 2009. Radionuclides - reasons and teaching. Nuklearmedizin 48: 55-57 [in German].
3. Carlin S, Cunningham SH, Boyd M, McCluskey AG, Mairs RJ. 2000. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two- and three-dimensional models. Cancer Gene Therapy 7: 1529-1536.
4. Chen J. 2008. A compilation of microdosimetry for uniformly distributed Auger emitters used in medicine. International Journal of Radiation Biology 84: 1027-1033.
5. Freudenberg R, Andreeff M, Oehme L, Kotzerke J. 2009. Dosimetry of cell-monolayers in multiwell plates. Nuklearmedizin 48: 120-126 [in German].
6. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD cellular S values. Reston, VA: Society of Nuclear Medicine.
7. Haberkorn U, Altmann A, Jiang S, Morr I, Mahmut M, Eisenhut M. 2001. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene. European Journal of Nuclear Medicine 28: 633-638.
8. Haefliger P, Agorastos N, Renard A, Giambonini-Brugnoli G, Marty C, Alberto R. 2005. Cell uptake and radiotoxicity studies of an nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]?. Bioconjugate Chemistry 16: 582-587.
9. Howell RW. 1992. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 19: 1371-1383.
10. Howell RW. 2008. Auger processes in the 21st century. International Journal of Radiation Biology 84: 959-975.
11. Howell RW, Rajon D, Bolch WE. 2012. Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity. International Journal of Radiation Biology 88: 115-122.
12. Humm JL, Howell RW, Rao DV. 1994. Dosimetry of Auger-electronemitting radionuclides: Report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 21: 1901-1915.
13. Juweid M, Sharkey RM, Swayne LC, Griffiths GL, Dunn R, Goldenberg DM. 1998. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. Journal of Nuclear Medicine 39: 34-42.
14. Kassis AI. 2008. Therapeutic radionuclides: Biophysical and radiobiologic principles. Seminars in Nuclear Medicine 38: 358-366.
15. Kassis AI, Fayad F, Kinsey BM, Sastry KS, Taube RA, Adelstein SJ. 1987. Radiotoxicity of 125I in mammalian cells. Radiation Research 111: 305-318.
16. Kotzerke J, Rentschler M, Glatting G, Schneider E, Stabin M, Knapp FFJr, Reske SN. 1998. Dosimetry fundamentals of endovascular therapy using Re-188 for the prevention of restenosis after angioplasty. Nuklearmedizin 37: 68-72 [in German].
17. Kotzerke J, Glatting G, Seitz U, Rentschler M, Neumaier B, Bunjes D, Duncker C, Dohr D, Bergmann L, Reske SN. 2000. Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: Differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs. Journal of Nuclear Medicine 41: 531-537.
18. Kriehuber R, Kadenbach K, Schultz F, Weiss DG. 2004. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc. International Journal of Radiation Biology 80: 875-880.
19. Lambert B, Bacher K, Defreyne L, Gemmel F, Van Vlierberghe H, Jeong JM, Dierckx RA, Van de Wiele C, Thierens H, De Vos F. 2005. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: A phase I clinical trial. Journal of Nuclear Medicine 46: 60-66.
20. Leoni SG, Galante PA, Ricarte-Filho JC, Kimura ET. 2008. Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3. Genomics 91: 356-366.
21. Makrigiorgos GM, Adelstein SJ, Kassis AI. 1989. Limitations of conventional internal dosimetry at the cellular level. Journal of Nuclear Medicine 30: 1856-1864.
22. Maxon HR 3rd, Schroder LE, Washburn LC, Thomas SR, Samaratunga RC, Biniakiewicz D, Moulton JS, Cummings D, Ehrhardt GJ, Morris V. 1998. Rhenium-188(Sn)HEDP for treatment of osseous metastases. Journal of Nuclear Medicine 39: 659-663.
23. Meller B, Deisting W, Wenzel BE, Pethe A, Nadrowitz R, Meller J, Richter E, Baehre M. 2006. Increased radioiodine uptake of thyroid cell cultures after external irradiation. Strahlentherapie und Onkologie 182: 30-36.
24. Narra VR, Sastry KS, Goddu SM, Howell RW, Strand SE, Rao DV. 1994. Relative biological effectiveness of 99mTc radiopharmaceuticals. Medical Physics 21: 1921-1926.
25. Neti PV, Howell RW. 2006. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals. Journal of Nuclear Medicine 47: 1049-1058.
26. Pedraza-Lopez M, Ferro-Flores G, Mendiola-Cruz MT, Morales- Ramirez P. 2000. Assessment of radiation-induced DNA damage caused by the incorporation of 99mTc-radiopharmaceuticals in murine lymphocytes using single cell gel electrophoresis. Mutation Research 465: 139-144.
27. Perillo-Adamer F, Kosinski M, Dupertuis YM, Viertl D, Bischof Delaloye A, Buchegger F. 2009. Fluorodeoxyuridine mediated cell cycle synchronization in S-phase increases the Auger radiation cell killing with 125I-iododeoxyuridine. Nuklearmedizin 48: 233-242.
28. Pomplun E, Terrissol M, Kummerle E. 2006. Estimation of a radiation weighting factor for 99mTc. Radiation Protection Dosimetry 122: 80-81.
29. Pouget JP, Santoro L, Raymond L, Chouin N, Bardies M, Bascoul-Mollevi C, Huguet H, Azria D, Kotzki PO, Pelegrin M, et al. 2008. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiation Research 170: 192-200.
30. Schipper ML, Riese CG, Seitz S, Weber A, Behe M, Schurrat T, Schramm N, Keil B, Alfke H, Behr TM. 2007. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. European Journal of Nuclear Medicine and Molecular Imaging 34: 638-650.
31. Silva CR, Valsa JO, Canine MS, Caldeira-de-Araujo A, Bernardo-Filho M. 1998. Evaluation of technetium-99m decay on Escherichia coli inactivation: Effects of physical or chemical agents. Yale Journal of Biology and Medicine 71: 7-14.
32. Tavares AA, Tavares JM. 2010. (99m)Tc Auger electrons for targeted tumour therapy: A review. International Journal of Radiation Biology 86: 261-270.
33. Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, WolffJ. 2003. Anion selectivity by the sodium iodide symporter. Endocrinology 144: 247-252.
34. Wendisch M, Drechsel J, Freudenberg R, Runge R, Wunderlich G, Kotzerke J. 2009. Cellular damage in vitro. Nuklearmedizin 48: 208-214 [in German].
35. Wendisch M, Freudenberg R, Drechsel J, Runge R, Wunderlich G, Kotzerke J. 2010. 99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I. Nuklearmedizin 49: 154-160 [in German].